KR20070069123A - Calcium binding amino acid - Google Patents
Calcium binding amino acid Download PDFInfo
- Publication number
- KR20070069123A KR20070069123A KR1020077000101A KR20077000101A KR20070069123A KR 20070069123 A KR20070069123 A KR 20070069123A KR 1020077000101 A KR1020077000101 A KR 1020077000101A KR 20077000101 A KR20077000101 A KR 20077000101A KR 20070069123 A KR20070069123 A KR 20070069123A
- Authority
- KR
- South Korea
- Prior art keywords
- calcium
- amino acid
- bone
- fish
- bone frame
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 38
- 102000005701 Calcium-Binding Proteins Human genes 0.000 title description 5
- 108010045403 Calcium-Binding Proteins Proteins 0.000 title description 5
- 239000011575 calcium Substances 0.000 claims abstract description 76
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 76
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 75
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 57
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 41
- 235000019688 fish Nutrition 0.000 claims abstract description 25
- 241000251468 Actinopterygii Species 0.000 claims abstract description 23
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 21
- 150000007524 organic acids Chemical class 0.000 claims abstract description 16
- 241001454694 Clupeiformes Species 0.000 claims abstract description 6
- 241001465754 Metazoa Species 0.000 claims abstract description 6
- 235000019513 anchovy Nutrition 0.000 claims abstract description 6
- 239000006228 supernatant Substances 0.000 claims abstract description 5
- 241000251730 Chondrichthyes Species 0.000 claims abstract description 4
- 241000287828 Gallus gallus Species 0.000 claims abstract description 4
- 210000000845 cartilage Anatomy 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 14
- 239000011574 phosphorus Substances 0.000 claims description 9
- 229910052698 phosphorus Inorganic materials 0.000 claims description 9
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- 102000004169 proteins and genes Human genes 0.000 claims description 7
- 108090000623 proteins and genes Proteins 0.000 claims description 7
- 102000008186 Collagen Human genes 0.000 claims description 6
- 108010035532 Collagen Proteins 0.000 claims description 6
- 229920001436 collagen Polymers 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 4
- 239000008280 blood Substances 0.000 claims description 4
- -1 Calcium amino acid Chemical class 0.000 claims description 3
- 235000015277 pork Nutrition 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 2
- 238000004108 freeze drying Methods 0.000 claims description 2
- 238000001694 spray drying Methods 0.000 claims description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract description 18
- 239000003795 chemical substances by application Substances 0.000 abstract description 5
- 208000001132 Osteoporosis Diseases 0.000 abstract description 2
- 239000007921 spray Substances 0.000 abstract description 2
- BHEPBYXIRTUNPN-UHFFFAOYSA-N hydridophosphorus(.) (triplet) Chemical compound [PH] BHEPBYXIRTUNPN-UHFFFAOYSA-N 0.000 abstract 2
- 239000002778 food additive Substances 0.000 abstract 1
- 235000013373 food additive Nutrition 0.000 abstract 1
- 230000002787 reinforcement Effects 0.000 abstract 1
- 229960005069 calcium Drugs 0.000 description 66
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 8
- 102000011632 Caseins Human genes 0.000 description 8
- 108010076119 Caseins Proteins 0.000 description 8
- 102000004190 Enzymes Human genes 0.000 description 8
- 108090000790 Enzymes Proteins 0.000 description 8
- 102000004157 Hydrolases Human genes 0.000 description 8
- 108090000604 Hydrolases Proteins 0.000 description 8
- 238000010521 absorption reaction Methods 0.000 description 8
- 229940088598 enzyme Drugs 0.000 description 8
- 238000000605 extraction Methods 0.000 description 8
- 229910052500 inorganic mineral Inorganic materials 0.000 description 8
- 239000011707 mineral Substances 0.000 description 8
- 235000010755 mineral Nutrition 0.000 description 8
- 230000007062 hydrolysis Effects 0.000 description 7
- 238000006460 hydrolysis reaction Methods 0.000 description 7
- 239000000047 product Substances 0.000 description 7
- 239000005018 casein Substances 0.000 description 6
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 6
- 235000021240 caseins Nutrition 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 6
- 239000003655 absorption accelerator Substances 0.000 description 5
- 239000001506 calcium phosphate Substances 0.000 description 5
- 229910000389 calcium phosphate Inorganic materials 0.000 description 5
- 235000011010 calcium phosphates Nutrition 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 108010001441 Phosphopeptides Proteins 0.000 description 4
- 229910000019 calcium carbonate Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 4
- 238000011084 recovery Methods 0.000 description 4
- 102000008934 Muscle Proteins Human genes 0.000 description 3
- 108010074084 Muscle Proteins Proteins 0.000 description 3
- 102000057297 Pepsin A Human genes 0.000 description 3
- 108090000284 Pepsin A Proteins 0.000 description 3
- 102000004142 Trypsin Human genes 0.000 description 3
- 108090000631 Trypsin Proteins 0.000 description 3
- VSGNNIFQASZAOI-UHFFFAOYSA-L calcium acetate Chemical compound [Ca+2].CC([O-])=O.CC([O-])=O VSGNNIFQASZAOI-UHFFFAOYSA-L 0.000 description 3
- 239000001639 calcium acetate Substances 0.000 description 3
- 235000011092 calcium acetate Nutrition 0.000 description 3
- 229960005147 calcium acetate Drugs 0.000 description 3
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 3
- 239000001354 calcium citrate Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000000354 decomposition reaction Methods 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 235000013336 milk Nutrition 0.000 description 3
- 239000008267 milk Substances 0.000 description 3
- 210000004080 milk Anatomy 0.000 description 3
- 229940111202 pepsin Drugs 0.000 description 3
- 230000026731 phosphorylation Effects 0.000 description 3
- 238000006366 phosphorylation reaction Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 210000000813 small intestine Anatomy 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 235000013337 tricalcium citrate Nutrition 0.000 description 3
- 102000002322 Egg Proteins Human genes 0.000 description 2
- 108010000912 Egg Proteins Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 229940036811 bone meal Drugs 0.000 description 2
- 239000002374 bone meal Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 210000003278 egg shell Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 235000019640 taste Nutrition 0.000 description 2
- 239000012588 trypsin Substances 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 241000972773 Aulopiformes Species 0.000 description 1
- XGPIZUYXFXKEFK-UHFFFAOYSA-N B.P.P Chemical compound B.P.P XGPIZUYXFXKEFK-UHFFFAOYSA-N 0.000 description 1
- 229910014497 Ca10(PO4)6(OH)2 Inorganic materials 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 208000035150 Hypercholesterolemia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 108010038807 Oligopeptides Proteins 0.000 description 1
- 102000015636 Oligopeptides Human genes 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- CPGKMLVTFNUAHL-UHFFFAOYSA-N [Ca].[Ca] Chemical compound [Ca].[Ca] CPGKMLVTFNUAHL-UHFFFAOYSA-N 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 238000001354 calcination Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 235000021321 essential mineral Nutrition 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000004118 muscle contraction Effects 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 108091005981 phosphorylated proteins Proteins 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 230000002797 proteolythic effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 235000019515 salmon Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L17/00—Food-from-the-sea products; Fish products; Fish meal; Fish-egg substitutes; Preparation or treatment thereof
- A23L17/65—Addition of, or treatment with, microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2200/00—Function of food ingredients
- A23V2200/30—Foods, ingredients or supplements having a functional effect on health
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Microbiology (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Description
칼슘은 인체에 가장 많이 존재하는 무기질 원소로써 일반 성인의 경우 체중의 약 2%인 1200gr정도를 체내에 보유하고 있다. 체내칼슘의 99%는 골격과 치아를 형성하고 있으며 나머지 1% 정도만이 근육의 수축과 이완, 규칙적 심장박동, 혈액응고, 효소의 활성화, 세포내의 자극과 흥분의 전달과 같은 생리활성 조정기능을 담당하고 있다.Calcium is the most abundant mineral in the human body and has about 1200gr, which is about 2% of body weight in normal adults. 99% of the calcium in the body forms the skeleton and teeth, and only about 1% is responsible for the regulation of physiological activities such as muscle contraction and relaxation, regular heartbeat, blood coagulation, enzyme activation, intracellular stimulation and excitation delivery. Doing.
특히, 칼슘은 골다공증을 비롯하여 고콜레스테롤증, 동맥경화, 고지혈증, 고혈압, 등의 만성질환의 발생을 감소시키는 중요한 역할을 하므로, 적절한 칼슘영양상태가 항상 유지되어야 한다. 칼슘의 일일권장량은 700mg 정도로 음식물을 통한 칼슘의 섭취가 매우 중요하나 실질적으로는 칼슘을 함유하는 음식을 섭취하여도 체내에서의 칼슘의 흡수율이 매우 낮기 때문에 성인의 경우 권장량의 평균 30% 이하, 최대45%정도 만을 섭취하고 있는 실정이다.In particular, calcium plays an important role in reducing the incidence of chronic diseases such as osteoporosis, hypercholesterolemia, arteriosclerosis, hyperlipidemia, hypertension, and the like, and therefore, proper calcium nutrition should be maintained at all times. The daily recommended amount of calcium is about 700mg. It is very important to consume calcium through food, but in fact, even if you eat foods containing calcium, the absorption rate of calcium in the body is very low. Only 45% of the situation is ingested.
칼슘이 체내에서 흡수되기 위해서는 칼슘이 흡수되는 부위인 소장에서 점막세포를 통과할 때 반드시 가용성 형태로 존재하여야하며 이온의 상태로 존재해야 흡수될 수 있다는 것이 일반적인 학설이다. 그러나 소장 내는 약알카리성이므로 필수 무기질인 칼슘이 이온상태로 존재한다는 것은 불가능한 일이다. 따라서 칼슘은 특수한 구조물에 의존하지 않고서는 점막에서 이온의 상태를 유지할 수 없다. 즉 위장에서 생성된 수용성 미네랄 이온은 특수한 구조를 가진 화합물의 보호를 받지 못하면 십이지장을 통과하는 동안 과량의 인산과 결합하므로써 비흡수성 무기질인 인산칼슘으로 되어 분으로 배출되어버리고 만다In order for calcium to be absorbed in the body, it must be present in soluble form when passing through mucosal cells in the small intestine where calcium is absorbed. However, because the small intestine is weakly alkaline, it is impossible for calcium, an essential mineral, to exist in an ionic state. Therefore, calcium cannot maintain the state of ions in the mucosa without relying on special structures. In other words, when water-soluble mineral ions produced in the stomach are not protected by a specially structured compound, they are combined with excess phosphoric acid during the duodenum, resulting in non-absorbing mineral calcium phosphate, which is released into the powder.
대표적인 상용칼슘제는 화학적 합성품인 탄산칼슘, 인산칼슘, 등의 불용성 칼슘과 염화칼슘, 구연산칼슘, 초산칼슘 등의 수용성 염의 형태로 공급되며, 천연칼슘제로서는 우골분,어골분, 난각분,패각분,산호분 등 분쇄 및 소성에의한 단순가공 형태의 불용성 칼슘제로써 널리 공급되고 있다.Representative commercial calcium agents are supplied in the form of insoluble calcium such as calcium carbonate, calcium phosphate, etc., which are chemical synthetic products, and water-soluble salts such as calcium chloride, calcium citrate, calcium acetate, and the like. It is widely supplied as an insoluble calcium agent in the form of simple processing by grinding and calcining.
한편 상용 칼슘제의 인체내 흡수율을 개선시키기 위하여 이용되는 칼슘흡수촉진제로서는 단백질을 특정 효소로 분해하여 얻은 올리고펩티드(oligo-peptide)와, 특정 단백질이나 펩티드를 화학적으로 수식한, 인산화 단백질 혹은 펩티드를 이용하려는 시도가 행해지고 있다. 이중 가장 널리 알려진 기술은 우유에 들어있는 카제인 단백질을 효소인 트립신으로 가수분해시켜 만든 C.P.P(casein phospho peptide) 로 카제인의 serine잔기가 인산화 되어 있어 소장내 가용성 칼슘과 결합하여 체내흡수를 용이하게 해주는 물질로 알려져 있다(Naito등:Agricultural and Biological chemistry,36:409-,1972).Meanwhile, as calcium absorption accelerators used to improve the absorption rate of commercially available calcium agents in the human body, oligopeptides obtained by decomposing proteins with specific enzymes and phosphorylated proteins or peptides chemically modified with specific proteins or peptides are used. Attempts are being made. The most well-known technique is CPP (casein phospho peptide) made by hydrolyzing casein protein in milk with enzyme trypsin, which is phosphorylated with serine residue of casein, which is combined with soluble calcium in the small intestine to facilitate the absorption of the body. Naito et al .: Agricultural and Biological chemistry, 36: 409-, 1972.
또한 우유단백질인 카제인의 트립신 분해에 의해 분해물이 칼슘,철 등의 금속이온과 결합하고 가용성 복합체를 형성하며 체외로 배설되는 인산칼슘 등 불용성 물질의 형성을 방지하는 효과가 있음이 밝혀져 있다(Reeves 등:Science, 128:474-. 1958).In addition, trypsin decomposition of casein, a milk protein, has been shown to be effective in preventing the formation of insoluble substances such as calcium phosphate which is combined with metal ions such as calcium and iron, forms soluble complexes and is excreted outside the body (Reeves et al.). Science, 128: 474-. 1958).
상기의 선행 특허기술로서 예를 들면, 어류로부터 골을 분리하여 건조시킨 어골분을 제조하는 방법(일본 특개 평 제 2-231059호, 일본 특개 평 제 4-121166호)이 공지되어 있지만, 수분의 건조에 많은 에너지가 필요하다. 또한 , 어류의 중골을 고압수에서 세정한 후 잔존하는 단백질을 단백질 가수분해효소로 분해하고, 세정 제거한 다음 처리된 중골을 진공 가열 증발법으로 건조한 후 분쇄하여 어골분을 제조하는 방법(일본 특개 평 제 2-231059호)이 공지되어 있지만, 이렇게 제조된 제품의 칼슘함량이 낮은게 단점이다. 한편 상가한 문제점을 해결하기 위해 일본 특개 평 제 6-319487호에는 어류의 골을 초산에 침적시킴으로써 연화시키는 방법에 의해 수용성 칼슘을 제조하는 방법을 제시하고 있지만, 공정이 복잡하고, 액체형태의 음료 이외에는 사용할 수 없으므로 용도가 한정되어 있어 널리 이용되지 않고 있다.As the above-mentioned prior art, for example, a method for producing fish bone powder obtained by separating bones from fish and drying them (Japanese Patent Laid-Open No. 2-231059, Japanese Patent Laid-Open No. 4-121166) is known. It takes a lot of energy to dry. In addition, after washing the fish bones in high pressure water to decompose the remaining protein by protein hydrolase, washing and removing the dried bones by vacuum heating evaporation method and then pulverized to produce fish bone meal (Japanese Patent Laid-Open 2-231059) is known, but the low calcium content of the product thus produced is a disadvantage. On the other hand, in order to solve the additional problem, Japanese Patent Laid-Open No. 6-319487 discloses a method for producing water-soluble calcium by softening by dipping fish bones in acetic acid, but the process is complicated and liquid beverage Since it cannot be used other than this, its use is limited and it is not widely used.
국내의 관련 선행 특허기술 로서는 특허 제 10-0403284호 밑 특허 제 10-0399722호 등에서 어류의 골로부터 어골분, 수용성칼슘, 및 칼슘흡수촉진 펩티드를 제조하는 방법 등을 공지하고 있지만, 특정 가수분해효소를 참치 내장으로부터 추출하는 공정 등 공정이 복잡하고, 수용성 칼슘의 경우 상품수율이 낮아 경제적인 관점에서 널리 이용되가가 어려웠다.As a related prior patent technology in Korea, Patent No. 10-0403284 and Patent No. 10-0399722, etc. disclose a method of preparing fish bone meal, water-soluble calcium, and calcium absorption promoting peptides from fish bones, but specific hydrolase enzymes are known. The process of extracting tuna from internal organs is complicated, and in the case of water-soluble calcium, it is difficult to be widely used from an economic point of view because of low yield of commodities.
또한, 전세계적으로 널리 상용되고 있는 칼슘흡수촉진제인 C.P.P(casein phospho peptide)를 제조하는 선행기술로서는 미국특허 제 4,358,465(1982)호 밑 일본특허공보(평 2-7616, 1990) 등 이 있으며, 위 기술은 카제인나트륨의 분해시에 이용되는 효소의 종류 및 분리, 정제방법 등에서 만 미세한 차이가 있을 뿐 원리와 공정은 동일하여, 가수분해공정과 분리정제공정, 그리고 화학합성품인 칼슘을 인위적으로 첨가하여 ,C.P.P와 결합시킨 후 건조하는 공정으로 구성된다.In addition, the prior art for producing a casein phospho peptide (CPP), a calcium absorption accelerator that is widely used around the world, there is a Japanese Patent Publication (Heb. 2-7616, 1990) and the like under US Patent No. 4,358,465 (1982), The technology differs only in the kind of enzymes used for the decomposition of sodium casein, separation and purification methods, but the principles and processes are the same. Therefore, the hydrolysis process, the separation and purification process, and the chemical synthesis of calcium are artificially added. It is combined with CPP and dried.
기술적 과제Technical challenge
현재 상용중인 천연칼슘소재로는 탄산칼슘(Calcium carbonate)인 산호칼슘,패각칼슘,난각칼슘 등이 , 인산칼슘(Calcium phosphate)군은 우골분, 어골분 등이 있지만, 우골분은 광우병 파동으로, 난각칼슘,패각칼슘은 중금속 오염에 대한 F.D.A 등의 경고 및 흡수율에 대한 문제로 거의 사용되지 않고 있다. 화학적 합성품으로 이용되는 Calcium carbonate, Calcium phosphate등의 난용성 칼슘은 우유 등에 첨가시 침전되어 상품의 안정성에 결함을 노출시키는 반면에, 젖산칼슘(Calcium lactate), 구연산칼슘(Calcium citrate),초산칼슘(Calcium acetate)등의 수용성 칼슘은 일정량 이상 첨가시 맛의 변화가 심할 뿐 아니라 우유내의 카제인 단백질과의 반응으로 인한 응집발생 및 열처리 과정에서의 점도의 증가 및 겔화로 인한 쓴맛이 증가하는 등의 치명적인 단점을 노출시켜 왔다.Currently, natural calcium materials such as calcium carbonate (calcium carbonate), calcium calcium, shell calcium, eggshell calcium, etc. Calcium phosphate (Calcium phosphate) group includes cow bone powder, bone bone powder, but bone bone powder is a wave of mad cow disease, Eggshell calcium and shell calcium are rarely used as a warning about the heavy metal contamination and the problem of absorption rate. Insoluble calcium such as Calcium carbonate and Calcium phosphate, which are used as chemical compounds, precipitates when added to milk, exposing defects to product stability, whereas calcium lactate, calcium citrate, and calcium acetate (Calcium citrate) Water-soluble calcium, such as Calcium acetate, has a severe taste change when added over a certain amount, as well as fatal changes such as aggregation caused by reaction with casein protein in milk, viscosity increase during heat treatment, and bitter taste due to gelation. Has been exposed.
한편, C.P.P(casein phospho peptide)는 수용성 칼슘흡수촉진제로서 널리 상용되는 유일한 소재로서 흡수촉진용 펩티드인 C.P.P기본형과, C.P.P기본형에 인위적으로 칼슘을 첨가하여 칼슘이 결합된 상태로 고급형인 두가지 종류가 있으며, 제조공정이 복잡하고 고가인 관계로 널리 이용되지 못하는 한계점을 가지고 있다.On the other hand, CPP (casein phospho peptide) is the only material widely used as a water-soluble calcium absorption accelerator, and there are two types of CPP basic type, which is an absorption promoting peptide, and high-grade type in which calcium is added by artificially adding calcium to the CPP basic type. However, due to the complicated and expensive manufacturing process, it has limitations that cannot be widely used.
기술적 해결방법Technical solution
본 발명은 상술한 종래의 문제점을 해결하기 위한 것으로서,본 발명의 목적은 안전성이 검증된 천연칼슘소재로서, 수용성이며, 제품에 첨가시 맛의 변화와, 침전, 결합 등에 의한 상품의 안정성에 영향을 미치지 않으며, 단순하고, 효율적인 공정으로 제조 가능한 아미노산칼슘을 제공하는 데 있다.The present invention is to solve the above-mentioned problems, the object of the present invention is a natural calcium material that has been proven safe, water-soluble, affects the stability of the product due to changes in taste, precipitation, bonding, etc. when added to the product To provide a calcium calcium amino acid that can be produced in a simple, efficient process.
유리한 효과Favorable effect
이상에서 설명한 바와 같이, 본 발명에 따른 아미노산칼슘은 천연칼슘소재인 어골프레임으로부터 안전하고, 인체내 흡수율이 매우 우수한 아미노산이 결합된 칼슘의 제조를 가능하게 하였으며, 또한 칼슘흡수촉진제의 병용이 불필요한 고농도의 천연칼슘제이다.As described above, the amino acid calcium according to the present invention is safe from the fish bone frame, which is a natural calcium material, enables the production of calcium with amino acids combined with excellent absorption rate in the human body, and also has a high concentration that does not require the use of calcium absorption accelerators in combination. It is made of natural calcium.
도1은 어골 프레임으로부터 무기질칼슘과 아미노산펩티드의 최적 추출조건을 결정하기 위한 조건별 가수분해도를 나타낸 그래프이다.1 is a graph showing the degree of hydrolysis according to conditions for determining the optimal extraction conditions of mineral calcium and amino acid peptide from the bone frame.
도2는 어골 프레임으로부터 아미노산 칼슘 제조의 최적 조건의 결정을 위한 조건별 칼슘의 회수율을 나타낸 그래프이다.Figure 2 is a graph showing the recovery rate of calcium for each condition for the determination of optimal conditions for the production of amino acid calcium from the bone frame.
도3은 아미노산 펩티드와 추출된 칼슘의 결합능력을 확인하기 위한 아미노산 펩티드의 인산화 여부를 I.R-spectrum을 이용하여 확인한 결과를 나타낸 그래프이다.Figure 3 is a graph showing the results confirmed using I.R-spectrum phosphorylation of amino acid peptides to confirm the binding capacity of the amino acid peptide and the extracted calcium.
발명의 실시를 위한 최선의 형태Best Mode for Carrying Out the Invention
상기한 목적을 달성하기 위하여 본 발명에 따른 아미노산칼슘은, 어골프레임에 식용 가능한 유기산과 단백질 가수분해효소를 동시에 넣어 반응시켜, 상기 어골프레임으로부터 인과 칼슘이 용출되고, 단백지이 아미노산펩티드로 분해되면, 상기 아미노산펩티드와 상기 인이 결합하여 아미노산펩티드가 인산화되고, 인산화된 아미노산펩티드와 칼슘이 결합하여 생성된 것을 특징으로 한다.In order to achieve the above object, the amino acid calcium according to the present invention is prepared by reacting an edible organic acid and a protein hydrolase at the same time in the bone frame, and phosphorus and calcium are eluted from the bone frame, and the protein is broken down into amino acid peptides. The amino acid peptide and the phosphorus bond is characterized in that the amino acid peptide is phosphorylated, and the phosphorylated amino acid peptide and calcium is produced by binding.
또한, 상기 유기산 1~10%용액을 기준으로 상기 어골프레임 1%, 상기 어골프레임기준으로 가수분해효소 1%를 4~12시간 교반시켜 반응시킨 것이 바람직하다.In addition, it is preferable to react by stirring 1% of the fish bone frame based on the 1-10% solution of the organic acid and 1% of the hydrolase based on the fish bone frame for 4 to 12 hours.
또한, 상기 유기산 1~10%용액을 기준으로 상기 어골 프레임 1%, 상기 어골프레임 기준으로 가수분해효소 1%를 4~12시간 교반시켜 반응시킨 것이 바람직하다.In addition, it is preferable that 1% of the fish bone frame and 1% of the hydrolase are stirred for 4 to 12 hours on the basis of the 1-10% solution of the organic acid.
또한, 상기 칼슘이 결합된 인산화된 아미노산펩티드를 여과 및 원심분리하여 상층액을 취한 후 동결건조 또는 분무건조한 것이 바람직하다.In addition, the calcium-phosphorylated phosphorylated amino acid peptide is preferably filtered and centrifuged to take a supernatant and then lyophilized or spray dried.
또한, 상기 어골프레임 대신에 상어연골, 우골, 돈골, 닭뼈 중 어느 하나인 것이 바람직하다.In addition, it is preferable that any one of shark cartilage, right bone, pork bone, chicken bone instead of the bone frame.
발명의 실시를 위한 형태Embodiment for Invention
〔실시예 1〕 어골 프레임으로부터 가수분해 펩티드의 제조와 칼슘의 추출Example 1 Preparation of Hydrolyzed Peptides and Extraction of Calcium from Fishbone Frame
교반기가 부착된 반응기내에 10%초산용액(pH:2.0-2.2)을 기준으로 습식분쇄한 어골(hoki)프레임 1%(건조중량 기준)와 효소(pepsin) 1%(어골프레임 기준)를 투입하였다. 완만한 교반으로, 40℃, 12시간 반응시킨 후 여과 및 원심분리하여 상층액을 취하는 방법으로 무기질이 다량 함유된 가수분해 펩티드 조성물을 얻었다.Into a reactor equipped with a stirrer, 1% of a wet crushed hoki frame (based on dry weight) and 1% of a pepsin (based on a bone frame) based on 10% acetic acid solution (pH: 2.0-2.2) were added. . The reaction mixture was stirred at 40 ° C. for 12 hours with gentle stirring, and then filtered and centrifuged to obtain a supernatant to obtain a hydrolyzed peptide composition containing a large amount of minerals.
한편, 가수분해 및 무기질의 최적 추출조건을 얻기 위하여 동일한 반응조건에서 효소를 미 첨가한 대조구와 유기산을 미 첨가(증류수, pH조정)한 대조구를 설정한 후 가수분해도와 칼슘의 회수율을 비교하였다.On the other hand, in order to obtain the optimum conditions for hydrolysis and mineral extraction, the control group without the enzyme and the control group without the organic acid (distilled water, pH adjustment) were set under the same reaction conditions, and then the hydrolysis and calcium recovery were compared.
그 결과는 도 1에서 보는 바와 같이, 어골프레임의 가수분해율은 유기산 및 가수분해효소를 각각 처리하였을 경우 약 25% 및 40%를 나타내었으나, 유기산과 효소처리를 조합한 경우 약 70%가 가수분해되었다(As a result, as shown in FIG. 1, the hydrolysis rate of the fish bone frame was about 25% and 40% when the organic acid and the hydrolase were treated, respectively, but about 70% when the organic acid and the enzyme treatment were combined. (
한편 칼슘의 회수율은 도 2에서와 같이, 어골프레임으로부터 칼슘의 회수율을 비교해 본 결과, 유기산과 가수분해효소를 조합하여 처리한 경우 칼슘의 함량 및 수율이 모두 높게 나타났다.On the other hand, the recovery rate of calcium, as shown in Figure 2, when comparing the recovery rate of calcium from the fish bone frame, when the combination of the organic acid and hydrolase, both the content and yield of calcium was high.
〔실시예 2〕 어골프레임의 추출 무기질인 칼슘 및 인과 가수분해된 아미노산펩티드로 부터 인산화된 아미노산 펩티드(칼슘결합펩티드:아미노산펩티드:C.B.P.P )의 제조Example 2 Preparation of Phosphorylated Amino Acid Peptides (Calcium Binding Peptides: Amino Acid Peptides: C.B.P.P) from Calcium and Phosphorus Hydrolyzed Amino Acid Peptides
교반기가 부착된 반응기내에 10%초산용액(pH:2.0-2.2)을 기준으로 습식분쇄한 어골(hoki)프레임 1%(건조중량 기준)와 효소(pepsin) 1%(어골프레임, 건조중량 기준)를 투입하였다. 완만한 교반으로, 40℃, 12시간 반응시킨 후 여과 및 원심분리하여 상층액을 취한 후 동결건조하여 인산화펩티드 조성물을 얻었다.1% hoki frame (dry weight basis) and 1% pepsin (dry bone frame basis) wet-crushed in a reactor equipped with a stirrer based on 10% acetic acid solution (pH: 2.0-2.2) Was added. After gentle stirring, the reaction was carried out at 40 ° C. for 12 hours, followed by filtration and centrifugation. The supernatant was taken, and lyophilized to obtain a phosphorylated peptide composition.
한편,비인산화 펩티드의 대조구를 만들기 위하여 어골 성분을 완전히 제거한 근육 단백질(hoki, meat only,)만으로 구성된 기질을 이용하여 상기와 동일한 반응조건 하에서 비 인산화 팹티드 조성물을 동시에 제조하였다.On the other hand, in order to make a control of the non-phosphorylated peptide, a non-phosphorylated peptide composition was prepared simultaneously under the same reaction conditions using a substrate composed of muscle proteins (hoki, meat only, only) from which bone components were completely removed.
가수분해되 아미노산팹티드의 칼슘결합능력은 아미노산팹티드의 인산화(phosphorylation)여부에 의하여 결정되며 이를 확인하기 위하여 상기의 조성물 들에 대한 I.R-spectrum을 비교 확인하였다.The calcium binding capacity of the hydrolyzed amino acid peptide was determined by the phosphorylation of the amino acid peptide and compared with the I.R-spectrum for the above compositions to confirm this.
도 3에서와 같이, 비인산화 팹티드와 인산화 팹티드와의 차이는 인산그룹이 존재하는 1,000-1,300 cm-1에서 발견되었으며 그 peak들은 비 인산화 팹티드에서는 확인 되지 않았지만 인산화 팹티드에서 발견되었다. 즉, P=O 결합은 1,300cm-1에서, P-O-C 결합은 1,100-1,200cm-l에서, alkyl group과 결합된 -O-P는 1,000cm-1 에서 흡수띠를 나타내었다. 이러한 흡수띠들은 비 인산화 팹티드에서는 확인되지 않았지만 인산화 팹티드에서는 모든 시료에서 확인되었다.As shown in FIG. 3, the difference between the non-phosphorylated and phosphorylated peptides was found at 1,000-1,300 cm −1 where the phosphate group was present, and the peaks were found in the phosphorylated peptide, although the peaks were not identified. That is, P = O bonds at 1,300cm-1, P-O-C bonds at 1,100-1,200cm-1, and -O-P bonded to alkyl groups showed absorption bands at 1,000cm-1. These bands were not found in non-phosphorylated peptides, but in all samples.
본 발명은 어골 프레임 이외의 상어연골, 우골, 돈골, 닭뼈, 생멸치, 건멸치 등에서도 적용가능하다.The present invention is applicable to shark cartilage, beef bone, pork bone, chicken bone, raw anchovy, dried anchovy, etc. other than the fish bone frame.
또한, 본 발명은 동물성 골조직 뿐 아니라 동물성 골조직 및 피(皮, 가죽)등을 이용하여 동물성 골조직 및 피의 구성성분인 콜라겐 유래의 아미노산펩티드를 포함한 아미노산칼슘을 제조할 수도 있다.In addition, the present invention may be used to prepare amino acid calcium containing amino acid peptides derived from collagen which is a component of animal bone tissue and blood using animal bone tissue as well as animal bone tissue and blood.
본 발명에서 천연 칼슘의 원료인 어골프레임(Fish Bone Frame; 어골에 근육단백질이 결합되어 있는 것)은 수산가공 공장에서 어류 등의 1차 처리(생선까스 제품의 어육절단후, 참치 및 연어 등의 횟감용 절단처리)후의 어골과 이에 부착된 근육단백질을 주 대상으로 하며 -30℃의 동결고에 보관하여 둔 것을 사용하였다.In the present invention, fish bone frame (Fish Bone Frame; that is the muscle protein is coupled to the fish bone) is a raw material of natural calcium in the fish processing factory (after fish meat cut of fish cutlet products, tuna and salmon, etc.) Fish bones after the cutting process for sashimi) and the muscle proteins attached to them were used as the main targets and stored in a freezer at -30 ℃.
본 발명에서 무기질 성분인, 칼슘과 인, 그리고 유기 아미노산 펩티드의 추출은 식용가능한 유기산에 의한 칼슘 및 인의 용출과, 단백질 가수분해효소에 의한 아미노산 펩티드의 추출공정을 동시에 조합하여 실시한다. 생체 내의 골은 콜라겐 및 비 콜라겐 단백질과 무기질 결합체인 수산화인회석(hydroxyapatite; Ca10(PO4)6(OH)2)로 구성되며, 뼈을 구성하고 있는 콜라겐은 구성 무기질인 수산화 인회석과 강력한 결합체를 이루어 일반 효소에 의해 분해되기 힘들지만, 수산화인회석의 기본 구성분자인 칼슘, 인 등 이 유기산에 의해 용출 될 뿐 만 아니라, 초산에 의한 콜라겐의 추출이 용이해 지면서 근육 및 뼈의 단백질이 효과적으로 분해가 되었으며, 칼슘도 단백질 분해산물과 함께 용이하게 회수할 수 있게 된다.In the present invention, the extraction of calcium, phosphorus and organic amino acid peptides, which are inorganic components, is carried out by simultaneously combining the elution of calcium and phosphorus with an edible organic acid and the extraction process of the amino acid peptide with proteolytic enzymes. Bone in vivo is composed of collagen and non-collagen protein and hydroxyapatite (Ca10 (PO4) 6 (OH) 2), which is an inorganic binder, and collagen constituting bone is a strong enzyme with hydroxyapatite, a constituent mineral, Although it is hard to be decomposed by hydroxyapatite, calcium and phosphorus, which are the basic constituents of hydroxyapatite, are not only eluted by organic acids, but also collagen is easily extracted by acetic acid, and muscle and bone proteins are effectively decomposed. It can be easily recovered along with the proteolytic products.
본 발명에 사용된 식용 가능한 유기산은 초산(5-10%, pH:2-3)이 가장 바람직하나 이에 한정되는 것은 아니며 식용가능한 젖산, 구연산, 개미산 등도 가능하다.The edible organic acid used in the present invention is most preferably, but not limited to acetic acid (5-10%, pH: 2-3), edible lactic acid, citric acid, formic acid and the like.
유기산과 함께 가수분해시 이용되는 가수분해 효소로는 펩신(pepsin)이나 트립신(tripsin)이 사용되며, 상기의 조건을 만족시키는 산성 영역에서 활성을 잃지 않는 모든 효소가 이에 해당된다.As hydrolase used in hydrolysis with organic acids, pepsin or trypsin is used, and all enzymes that do not lose their activity in an acidic region satisfying the above conditions are applicable thereto.
어골 프레임의 가수분해 및 무기질의 추출시 기질농도는 유기산 용액의 1-10%, 투입되는 효소의농도는 기질대비 1-5%, 가수분해 및 추출 소요시간은 4-12시간이 적당하며,상기의 조건 등은 경제성을 고려하여 범위 내에서 결정하여야 한다.Substrate concentration is 1-10% of organic acid solution, enzyme concentration is 1-5%, and hydrolysis and extraction time is 4-12 hours. The conditions, etc., shall be determined within the scope in consideration of economic feasibility.
상기의 추출공정에서 용출 된 칼슘과 인은, 용출 됨과 동시에 효소분해에 의하여 생성된 단백질의 부분 가수분해물인 아미노산펩티드의 인산화(phosphorylation)에 직접 관여하여 인산화 아미노산펩티드를 형성시키고, 형성된 인산화 아미노산펩티드의 강력한 결합력은 용출된 칼슘을 흡착하게 되어, 아미노산칼슘이 생성된다.Calcium and phosphorus eluted in the above extraction process are eluted and directly involved in the phosphorylation of amino acid peptides, which are partial hydrolysates of proteins produced by enzymatic decomposition, to form phosphorylated amino acid peptides, and to form phosphorylated amino acid peptides. The strong binding force absorbs the eluted calcium, producing the amino acid calcium.
상기의 추출 및 결합공정을 통하여 형성된 칼슘결합인산화펩티드(Calcium Binding Phospho Peptide:C.B.P.P)의 분리 및 정제는 여과시스템을 이용하여 분자 량 10,000 Da 이하 분획의 칼슘결합인산화펩티드만을 모아 동결건조 또는 분무건조하여 제조하였다.Separation and purification of Calcium Binding Phospho Peptide (CBPP) formed through the extraction and binding process is performed by filtration system, and only lyophilization or spray drying by collecting only calcium binding phosphate peptides with a molecular weight of 10,000 Da or less. Prepared.
본 발명의 방법에 따라 제조된 C.B.P.P는 칼슘 등의 무기질과 아미노산이 결합된 형태의 고농도의 천연수용성 칼슘제로서, 안전성 측면에서도 매우 우수한 소재이며, 칼슘흡수촉진제의 병용이 필요없는 그 자체로서 식품이나 음료, 건강보조식품 및 의약품의 원료로 사용될 수 있다.CBPP prepared according to the method of the present invention is a highly concentrated natural water-soluble calcium agent in the form of a combination of minerals such as calcium and amino acids, and is a very excellent material in terms of safety, and does not require the use of a calcium absorption accelerator as a food or beverage. It can also be used as a raw material for dietary supplements and pharmaceuticals.
Claims (5)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20050023889 | 2005-03-03 | ||
KR1020050023889 | 2005-03-03 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20070069123A true KR20070069123A (en) | 2007-07-02 |
Family
ID=37023938
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020077000101A KR20070069123A (en) | 2005-03-03 | 2005-11-14 | Calcium binding amino acid |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20070069123A (en) |
WO (1) | WO2006101301A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109123062A (en) * | 2018-06-22 | 2019-01-04 | 青岛海洋生物医药研究院股份有限公司 | A kind of preparation method and application of peptide calcium chelate |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103211229A (en) * | 2013-04-25 | 2013-07-24 | 福建永生活力生物工程有限公司 | Health food for increasing bone mineral density and preparation method thereof |
CN104982937B (en) * | 2015-07-31 | 2018-01-23 | 中科和素(天津)医药科技有限公司 | It is a kind of to promote sclerotin and the composition of periosteum for repairing and preparation method thereof |
CN105211892B (en) * | 2015-11-14 | 2017-12-19 | 中国海洋大学 | A kind of fish-bone calcium peptide chelate complex and preparation method thereof |
CN110604313A (en) * | 2019-09-30 | 2019-12-24 | 浙江海洋大学 | Method for preparing high-protein high-calcium supplement by using mussel waste materials |
CN111165827A (en) * | 2020-02-26 | 2020-05-19 | 福建鼍龙实业有限责任公司 | Crocodile peptide chelated calcium and preparation method and application thereof |
KR102437393B1 (en) * | 2020-04-29 | 2022-08-30 | 주식회사 대호 | Manufacturing method of growth promoters for livestock |
CN112006287B (en) * | 2020-07-30 | 2023-02-28 | 华中农业大学 | High-calcium high-collagen food and preparation method thereof |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2947484B2 (en) * | 1990-05-08 | 1999-09-13 | 雪印乳業株式会社 | Bone-fortified food, feed or osteoarthritis prophylactic or therapeutic drug |
KR100399722B1 (en) * | 2000-09-07 | 2003-09-29 | 김세권 | Preparation of fish bone powder and calcium absorption accelerating peptide using the enzyme from fish processing waste |
KR100403284B1 (en) * | 2000-09-07 | 2003-10-30 | 대한민국 | A method for extracting water-soluble calcium from fish bone |
KR100699324B1 (en) * | 2003-02-19 | 2007-03-23 | 나카가와모모키 | Method of producing protein hydrolysates from fish scale |
-
2005
- 2005-11-14 WO PCT/KR2005/003848 patent/WO2006101301A1/en active Application Filing
- 2005-11-14 KR KR1020077000101A patent/KR20070069123A/en not_active Application Discontinuation
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109123062A (en) * | 2018-06-22 | 2019-01-04 | 青岛海洋生物医药研究院股份有限公司 | A kind of preparation method and application of peptide calcium chelate |
Also Published As
Publication number | Publication date |
---|---|
WO2006101301A1 (en) | 2006-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104958756B (en) | A kind of chelated calcium preparation method of crocodile ossein | |
KR20070069123A (en) | Calcium binding amino acid | |
FitzGerald | Potential uses of caseinophosphopeptides | |
CN103230020B (en) | Preparation method of protein short peptide chelated calcium | |
CN101219211A (en) | Compound polypeptide composition, preparing method and uses of the same | |
JP2001211895A (en) | Method of producing physiologically active peptide | |
JP2947484B2 (en) | Bone-fortified food, feed or osteoarthritis prophylactic or therapeutic drug | |
JPS63258599A (en) | Production of enzyme protein hydrolysate rich in dipeptide and tripeptide | |
CN1231146C (en) | Process for preparing polypeptide bone powder | |
CA2704092C (en) | Food material for inhibiting osteoclastogenesis | |
CN1114146A (en) | Process for preparing compound amino-acid chelating salt and hydrolytic protein | |
JP2005119983A (en) | Nutritive composition | |
JPH027616B2 (en) | ||
CN113754759A (en) | Process for extracting multiple nutritional ingredients from fish scales | |
JP3742523B2 (en) | Polymeric calcium phosphopeptide complex | |
CN101130801A (en) | Preparation of active antihypertensive peptide product | |
KR100699047B1 (en) | Manufacturing method of calcium binding peptide | |
KR100399722B1 (en) | Preparation of fish bone powder and calcium absorption accelerating peptide using the enzyme from fish processing waste | |
FitzGerald et al. | Caseinphosphopeptides (CPPs) as functional ingredients | |
KR100479755B1 (en) | Method for producing soybean phosphopeptide calcium | |
JPWO2009057282A1 (en) | Food material for suppressing bone resorption | |
JP3372499B2 (en) | Foods and drinks with mineral absorption promoting action | |
JP3406367B2 (en) | Method for producing soy protein having mineral absorption promoting effect | |
JPH05284939A (en) | Beverage and food containing calcium | |
JPH0379979B2 (en) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
A302 | Request for accelerated examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |